A chemical compound that has had one or more of its atoms replaced by a radionuclide is known as a Radioactive Tracer, radiotracer, or radioactive label. Because of its radioactive decay, radioactive tracer compounds can be used to investigate the mechanism of chemical reactions by tracing the path that the radioisotope takes from reactants to products. Thus, the radioactive version of isotopic labelling is radiolabelling or radiotracing. The use of radioactive tracers is commonly referred to as radioisotope feeding experiments in biological contexts. It has been extensively used to follow the course of biological reactions to employ radioisotopes of hydrogen, carbon, phosphorus, sulfur, and iodine. A radioactive tracer can also be employed as a flow tracer or to monitor a substance's distribution inside a natural system like a cell or tissue. In the process of producing natural gas, radioactive tracers are also utilised to locate cracks caused by hydraulic fracturing. A number of imaging methods, including technetium scans, SPECT scans, and PET scans, are based on radioactive tracers. Carbon-14, an isotope that occurs naturally, is used in radiocarbon dating as an isotopic label.
Yong Xiao Wang
Albany Medical College, United States
Consolato M Sergi
Universities of Alberta and Ottawa, Canada
Vladlen Slepak
University of Miami Miller School of Medicine, United States
Andreas M Papas
Antares Health Products, United States
Bernd Blobel
University of Regensburg, Germany
Huiqin Yang
ICON Clinical Research Ltd, United Kingdom
Srividya Narayanan
Northeastern University, United States
Maria Richards Brown
University College London, United Kingdom
Rassa Pegahi
UPSA, France
Hanieh Khalili
University of East London, United KingdomSubmit your abstract Today
Title : Medical liver biopsy: Toward a personalized approach
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Emerging formulation and delivery applications of vitamin E TPGS
Andreas M Papas, Antares Health Products, United States
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through design-inspired biotech- & biopharma-driven applications and upgraded business marketing to secure the human healthcare and biosafety
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Mathematical modeling the disc diffusion test: Antibacterial activity of copper-doped SnO2
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Genetic keys and nano locks: Unlocking personalized medicine
Srividya Narayanan, Northeastern University, United States
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad Autónoma de Baja California, Mexico